NCT05951296: A trial that was reported late by Modern Biosciences Ltd
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT05951296 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Efficacy and Safety of Leramistat in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 30, 2023 |
| Completion date | July 31, 2024 |
| Required reporting date | July 31, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 10, 2025 |
| Days late | None |